Home > Insider Trading > Filing (0001179110-15-006889)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1436304	Kythera Biopharmaceuticals Inc	KYTH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573074	Frederick Iii Beddingfield	C/O Kythera Biopharmaceuticals 30930 Russell Ranch Road, Suite 300 Westlake Village CA 91362	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-29	5,409	$0.00	45,849	No	4	A	Direct
Common Stock	Disposition	2015-04-30	2,041	$45.51	43,808	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

On January 22, 2014, the Reporting Person was granted 5,409 restricted stock units (RSUs), with 100% of the RSUs to vest upon approval of the Issuer's New Drug Application (NDA) by the U.S. Food and Drug Administration. The NDA was approved on April 29, 2015. The Reporting Person received one (1) share of Common Stock for each one (1) RSU upon vesting.
Sale of shares to satisfy tax withholding obligations in connection with the vesting of the RSUs.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.05 to $45.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.